Medmira Capital Ltd. is > 10% Shareholder of HCW Biologics Inc.. Currently has a direct ownership of 0 shares of HCWB, which is worth approximately $0. The most recent transaction as insider was on Sep 15, 2021, when has been sold 3,587,659 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Medmira Capital Ltd. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 15 2021
SELL
Other acquisition or disposition
-
3,587,659 Reduced 100.0%
0 Common Stock
Jul 22 2021
BUY
Conversion of derivative security
-
3,587,661 Added 50.0%
3,587,661 Common Stock
MCL

Medmira Capital Ltd.

> 10% Shareholder
Nanshan Shenzhen, F4

Track Institutional and Insider Activities on HCWB

Follow HCW Biologics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCWB shares.

Notify only if

Insider Trading

Get notified when an Hcw Biologics Inc. insider buys or sells HCWB shares.

Notify only if

News

Receive news related to HCW Biologics Inc.

Track Activities on HCWB